Firefly Synergy Evoke is now part of Firefly Neuro, creating immediate cross selling opportunities to Firefly customers across neurology, psychiatry, and cognitive research. Leverage the broader cognitive electrophysiology platform to bundle the FDA cleared Evoke EEG System with AI powered analytics for real world clinical care. Use Firefly's go to market to accelerate adoption and scale from pilots to enterprise deployments.

Healthcare System Fit The FDA cleared Evoke EEG System provides objective brain biomarkers via cognitive event related potentials, supporting earlier detection, differential diagnosis, and treatment tracking. Hospitals and health systems pursuing value based care and enhanced patient outcomes are a natural fit for scalable brain health scans. There is potential for outcomes based contracts and bundled services.

Government & Research Historical USAF contract and other awards show readiness for government and academic partnerships. Target military medical centers, VA facilities, and neuroscience research labs for cognitive health screening programs and clinical studies. The acquisition by Firefly broadens access to platform level services that can power large scale trials.

Platform Upsell Evoke technology is positioned to scale across multiple domains including behavioral health, neurology, integrative medicine, and research. Pitch as a turnkey cognitive electrophysiology platform with ERP biomarkers, enabling longitudinal tracking of treatment impact. Potential to monetize through subscriptions, service renewals, and data analytics modules.

SMB Opportunity Current team size of 2-10 suggests lean sales; ideal for channel partnerships, distributors, and targeted pilots in private clinics and small to mid size health systems. Focus on scalable procurement options such as device sales complemented by cloud based analytics licenses and training services.